|
58
|
247
|
7zrtA |
Crystal structure of human urokinase-type plasminogen activator in complex with bicycle peptide inhibitor uk970 |
|
59
|
247
|
7zrrA |
Crystal structure of human urokinase-type plasminogen activator in complex with bicycle peptide inhibitor uk965 |
|
54
|
245
|
7vm7U |
Crystal structure of inactive upa in complex with nafamostat |
|
58
|
247
|
7vm6U |
Crystal structure of upa in complex with 6-amidino-2-naphthol |
|
56
|
246
|
7vm5U |
Crystal structure of upa in complex with 4-guanidinobenzoic acid |
|
56
|
245
|
7vm4U |
Crystal structure of upa in complex with nafamostat |
|
56
|
245
|
7dzdU |
Crystal structure of upa in complex with cleaved camostat |
|
56
|
246
|
6jypU |
Crystal structure of upa_h99y in complex with 3-azanyl-5-(azepan-1-yl)-n-[bis(azanyl)methylidene]-6-chloranyl-pyrazine-2-carboxamide |
|
55
|
246
|
6jyqU |
Crystal structure of upa_h99y in complex with 3-azanyl-5-(azepan-1-yl)-n-carbamimidoyl-6-(furan-2-yl)pyrazine-2-carboxamide |
|
0
|
9
|
3ig6C |
Low molecular weigth human urokinase type plasminogen activator 2-[6-(3'-aminomethyl-biphenyl-3-yloxy)-4-(3-dimethylamino-pyrrolidin-1-yl)-3,5-difluoro-pyridin-2-yloxy]-4-dimethylamino-benzoic acid complex |
|
53
|
259
|
6nmbA |
Tranexamic acid is an active site inhibitor of urokinase plasminogen activator |
|
53
|
247
|
6a8gA |
The crystal structure of mupain-1-ig in complex with mupa-spd at ph8.5 |
|
54
|
247
|
6a8nA |
The crystal structure of mupain-1-ig-2 in complex with mupa-spd at ph8.5 |
|
56
|
246
|
5zaeU |
Upa-6f-hma |
|
55
|
245
|
5zajU |
Upa-31f |
|
58
|
245
|
5za8U |
Upa-bb2-27f |
|
57
|
246
|
5za7U |
Upa-hma |
|
58
|
245
|
5zafU |
Upa-bb2-28f |
|
57
|
245
|
5zc5U |
Upa-nu-09f |
|
56
|
245
|
5za9U |
Upa-bb2-50f |
|
56
|
245
|
5zagU |
Upa-bb2-94f |
|
51
|
245
|
5zahU |
Upa-bb2-30f |
|
59
|
245
|
5z1cU |
The crystal structure of upa in complex with 4-iodobenzylamine at ph7.4 |
|
53
|
247
|
5lhqA |
The egr-cmk active site inhibited catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody nb7 |
|
48
|
247
|
5lhnA |
The catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody nb7 |
|
56
|
247
|
5lhrA |
The catalytic domain of murine urokinase-type plasminogen activator in complex with the active site binding inhibitory nanobody nb22 |
|
54
|
246
|
5yc6U |
The crystal structure of upa in complex with 4-bromobenzylamirne at ph4.6 |
|
56
|
247
|
5wxpU |
Crystal structure of upa in complex with upain-2-3-w3a |
|
51
|
246
|
5xg4U |
Crystal structure of upa in complex with quercetin |
|
59
|
247
|
4zkoU |
The crystal structure of upain-1-w3a in complex with upa at ph7.4 |
|
57
|
247
|
4zhlU |
The crystal structure of mupain-1-ig in complex with murinised human upa at ph7.4 |
|
56
|
246
|
4dvaU |
The crystal structure of human urokinase-type plasminogen activator catalytic domain |
|
38
|
241
|
4dw2U |
The crystal structure of upa in complex with the fab fragment of mab-112 |
|
19
|
123
|
3u73A |
Crystal structure of stabilized human upar mutant in complex with atf |
|
53
|
246
|
5yc7U |
The crystal structure of upa in complex with 4-bromobenzylamirne at ph7.4 |
|
57
|
245
|
5wxqU |
Crystal structure of upa in complex with upain-2-4 |
|
57
|
246
|
5wxsU |
Crystal structure of upa in complex with s2444 |
|
59
|
246
|
5wxfU |
Crystal structure of upa in complex with upain-2-2 |
|
58
|
245
|
5wxrU |
Crystal structure of upa in complex with upain-2-4-w3a |
|
58
|
245
|
5wxtU |
Crystal structure of upa-s195a in complex with s2444 |
|
59
|
246
|
5wxoU |
Crystal structure of upa in complex with upain-2-2-w3a |
|
58
|
246
|
4zksU |
The crystal structure of upain-1-w3a in complex with inactive upa (upa-s195a) at ph7.4 |
|
59
|
246
|
4zknU |
The crystal structure of upain-1-w3a in complex with upa at ph5.5 |
|
47
|
247
|
5lhpA |
The p-aminobenzamidine active site inhibited catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody nb7 |
|
37
|
238
|
5lhsA |
The ligand free catalytic domain of murine urokinase-type plasminogen activator |
|
54
|
246
|
4zkrU |
The crystal structure of upain-1-w3a in complex with upa at ph9.0 |
|
57
|
247
|
4zhmU |
The crystal structure of mupain-1--16-ig in complex with murinised human upa at ph7.4 |
|
59
|
246
|
5hggA |
Crystal structure of upa in complex with a camelid-derived antibody fragment |
|
57
|
246
|
4xskU |
Structure of paitrap, an upa mutant |
|
59
|
246
|
4x1sU |
The crystal structure of mupain-1-16-d9a in complex with murinised human upa at ph7.4 |
